Topic

Clinical Vice President, Internal Medicine, Signant Health

Articles

Poor representation of dark skin tones in textbooks emphasizes need for change.

Properly Training Physicians in Dermatology Trials

The diversified sources of the somatic cells call for additional oversight to prevent the introduction, transmission, and spread of communicable disease.

Somatic Cell Therapy—Navigating the Regulatory Landscape 

RWE can augment, extend, or enrich the findings from clinical trials to provide valuable evidence to support the development programs for product approvals. 

Augmenting Single Arm Oncology and Rare Disease Trials with Real World Evidence

Do Oncology Clinical Trial Participants Cost More for Payers?

Survey data shows individuals are not informed on how COVID-19 could affect their conditions.

Rare Disease Patients Overlooked During COVID

Developing new pathways to overcome study-related challenges is key to realizing the promise of the latest gene therapies.

The Rise of Gene Therapy: Advanced Regulatory, Site, and Enrollment Considerations

How partnering with a CRO that has experience in both dermatology and innovative trial approaches can help sponsors differentiate their studies and facilitate recruitment. 

Navigating the New World of Dermatology Trials

Thousands of trials have been halted as a consequence of the coronavirus pandemic, slowing the pace of scientific progress dramatically.

Cancer Won’t Wait for COVID to End: Conducting Trials Amid the Coronavirus Pandemic

Today's reality and the hopes of tomorrow of the COVID-19 pandemic—an updated mapping of vaccines authorized by regulatory bodies and those close to it.

Vaccines Approved and Under Development Against COVID-19

Though the fields of immunotherapy and cell and gene therapies have seen significant growth since April 2012, CGT clinical research remains a challenge.

Therapeutic Areas